1.TREATMENT OF MAJORLIN`S ULCER: THE ROLE OF COMBINATION CHEMOTHERAPY.
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1997;24(4):761-765
No abstract available.
Drug Therapy, Combination*
;
Ulcer*
2.Combination chemotherapy for the treatment of multiple myeloma.
Hyo Jin KIM ; Chang In SEO ; Keun Chil PARK ; Heung Tae KIM ; Dae Seog HEO ; Yung Hue BANG ; Seonyang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(4):577-585
No abstract available.
Drug Therapy, Combination*
;
Multiple Myeloma*
3.5-fluorouracil, epirubicin, cisplatin(FEP) and 5-fluorouracil, cisplatin(FP) combination chemotherapy for advanced pancreatic carcinoma.
Ki Hyeong LEE ; Won Ki KANG ; Chang In SUH ; Young Suk PARK ; Heung Tae KIM ; Yoon Koo KANG ; Hyo Jin KIM ; Dae Seog HEO ; Yung Jue BANG ; Yong Bum YOON ; Noe Kyeong KIM ; Yong Hyun PARK
Journal of the Korean Cancer Association 1991;23(2):315-322
No abstract available.
Drug Therapy, Combination*
;
Epirubicin*
;
Fluorouracil*
4.COP-BLAM III(cyclophosphamide/vincristine/prednisolone/bleomycin/ adriamycin/procarbazine) combination chemotherapy for the treatment of intermediate and high grade non-Hodgkin's lymphoma.
Keong Hae JUNG ; Young Iee PARK ; Kee Heung LEE ; Young Suk PARK ; Chang In SUH ; Won Ki KANG ; Heung Tae KIM ; Cheol Won SUH ; Dae Seog HEO ; Yung Jue BANG ; Seonyang PARK ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(4):586-595
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
5.Etoposide, adriamycin, cisplatin(EAP) combination chemotherapy for advanced gastric cancer.
Joon Sik KIM ; Jeong Hee KIM ; Own Gyu UH ; Si Young KIM ; Hwi Joong YOON ; Kyung Sam CHO
Journal of the Korean Cancer Association 1992;24(4):562-569
No abstract available.
Doxorubicin*
;
Drug Therapy, Combination*
;
Etoposide*
;
Stomach Neoplasms*
6.COP-BLAM V(cyclophosphamide/vincristine/prednisolone/bleomycin/ adriamycin/procarbazine) combination chemotherapy for the treatment of intermediate and high grade non-Hodgkin's lymphoma.
Young Iee PARK ; Kee Heung LEE ; Keong Hae JUNG ; Sung Soo YOON ; Yeong Huck IM ; Jung Soon JANG ; Jae Yong LEE ; Dae Suck HEO ; Yung Jue BANG ; Seonyang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(2):268-276
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
7.Mono- and Combination Chemotherapy for Metastatic Breast Cancer: An Increamental Step Forward.
Journal of Korean Breast Cancer Society 2003;6(3):137-140
No abstract available.
Breast Neoplasms*
;
Breast*
;
Drug Therapy, Combination*
8.Effect of combination therapy between sucrategel with amoxilline for Helicobacter pylori-induced chronic gastritis and for eradication of H. pylori: a histopathological study
Journal of Practical Medicine 2002;435(11):46-49
33 patients with H. pylori-induced chronic gastritis were treated by combination therapy with sucrategel and amoxicilline. Before and after treatment, the patients were given tests, included endoscopy and biopsy, histopathological test, urease test and culture for H. pylori. Histopathological findings before and after treatment were compared. The results showed that sucrategel plus amoxicilline combination was effective in H. pylori eradication in 51.51% of the patients. 42.42% of patients had remission in inflammatory or had normalization of gastric mucous membrane. For intestinal dysplasia, there was some improvement, but it was not concluded because of limitation in number of patients.
Gastritis
;
Helicobacter pylori
;
Drug Therapy, Combination
9.Modified COP-BLAM combination chemotherapy for the non-Hodgkin's lymphoma.
Journal of the Korean Cancer Association 1991;23(2):331-336
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
10.Gynecologic oncology group trials in uterine corpus malignancies: recent progress.
David Scott MILLER ; Louise P KING
Journal of Gynecologic Oncology 2008;19(4):218-222
The Gynecologic Oncology Group (GOG) has conducted multiple trials related to malignancies of the uterine corpus. Recently, several of these trials have been presented and/or published. Areas of focus included the feasibility of laparoscopic staging for endometrial cancer, the adjuvant management of locally advanced endometrial cancer, whole abdominal irradiation in maximally resected advanced endometrial carcinoma, and combination chemotherapy regimens for stage I and II carcinosarcoma after primary surgery and for advanced or recurrent carcinosarcoma. This article will discuss the background and details of each of these important advances.
Carcinosarcoma
;
Drug Therapy, Combination
;
Endometrial Neoplasms
;
Female
Result Analysis
Print
Save
E-mail